Tanya Golubchik

SARS-CoV-2 evolution during treatment of chronic infection

Steven A. Kemp, Dami A. Collier, Rawlings Datir et al. · Nature · 2021 · 1.1K citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity

Erik Volz, Verity Hill, John T. McCrone et al. · Cell · 2020 · 1.1K citations · Full text

Life Sciences, Genetics, Infectious Diseases +17

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

Brian J. Willett, Joe Grove, Oscar A. MacLean et al. · Nature Microbiology · 2022 · 724 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Dami A. Collier, Anna De Marco, Isabella A.T.M. Ferreira et al. · Nature · 2021 · 716 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

Katherine R. W. Emary, Tanya Golubchik, Parvinder K. Aley et al. · The Lancet · 2021 · 651 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17